Absorbable nasal implant devices are used to support both lower and upper lateral cartilage in the nose, strengthening the nasal wall such as polymer grafts and traditional cartilage. Such implants are used to treat nasal obstruction and allow the patient to breathe better and sleep. Nasal blockage or obstruction can be caused by several factors, such as enlarged turbinates, septal deviation, and weakened lower or/and upper lateral nasal cartilage, leading to vestibular stenosis (nasal valve collapse). Symptoms include congestion, stuffiness, or an inability to breathe through one or both nostrils.
Request PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/5
Nasal valve collapse is a term that refers to any weakness or further narrowing of the nasal valve. Absorbable nasal implant devices improve breathing and support the nasal cartilage. These nasal implants are generally preferred for those who have undergone a rhinoplasty because of the possibility of an extremely narrow-looking nose. Absorbable nasal implant devices are important for patients where a standard treatment procedure for turbinates and septum are not enough.
Market Dynamics:
Increasing demand for nasal implant devices and the increasing adoption of advanced nasal implants by physicians is expected to propel the growth of the absorbable nasal implant devices market. For instance, in 2018, Intersect ENT announced U.S. commercial availability of the SINUVA (mometasone furoate) Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery.
Moreover, increasing adoption of better health care facilities, large patient pool, and increasing awareness about advanced nasal reconstruction procedures is expected to augment the growth of the absorbable nasal implant devices market. However, subconscious awareness about implant creating discomfort, mild pain, or irritation and stringent regulatory guidelines are expected to hamper the growth of the absorbable nasal implant market.
North America is expected to witness substantial growth of the absorbable nasal implant devices market due to increasing number of nasal obstruction cases in the region. For instance, around 3 million people in the United States visit a physician for nasal obstruction and 1 million procedures are performed to alleviate the symptoms.
In June 2019, Stryker announced that more than 33,000 nasal valve collapse (NVC) patients have been treated with its LATERA absorbable nasal implant. LATERA is used to support the lateral nasal cartilage and address the symptoms of NVC, helping patients breathe better
Buy This Research Study Report For Quick Access@ https://www.coherentmarketinsights.com/insight/buy-now/5
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: [email protected]